Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02356614 · ClinicalTrials.gov registry record
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study
A clinical trial, sponsored by Apollo Endosurgery.
- Terminated
- Registry status
- 325
- Enrollment target
NCT02356614: Clinical Trial study, sponsored by Apollo Endosurgery.
NCT02356614 is a clinical trial that was terminated before completion, run by Apollo Endosurgery. The registered enrollment target is 325 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02356614 was terminated before completion, sponsored by Apollo Endosurgery.
- TERMINATED
- Registry status
- 325 participants
- Enrollment target
Study Summary
This is a post-approval, multicenter, prospective, non-randomized, open-label, clinical study to evaluate the safety and effectiveness of the LAP-BAND® AP System in a lower obese population (BMI ≥ 30 kg/m2 and \< 40 kg/m2) with one or more obesity-related comorbidity up to 10 years after implantation. The reason your study has been terminated is based on the availability of long-term safety and effectiveness data from the OSB Lead-HERo-002 study and published literature.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-03-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02356614
The ClinicalTrials.gov registry entry for NCT02356614 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Apollo Endosurgery, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02356614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02356614 about?
NCT02356614 is a clinical study titled "A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study". This is a post-approval, multicenter, prospective, non-randomized, open-label, clinical study to evaluate the safety and effectiveness of the LAP-BAND® AP System in a lower obese population (BMI ≥ 30 kg/m2 and \< 40 kg/m2) with one or more obesity-related comorbidity up to 10 years after implantatio...
What is the current status of trial NCT02356614?
This trial is currently terminated. The enrollment target is 325 participants. The study started on 2015-03. Estimated completion is 2018-03-08.
Who is sponsoring clinical trial NCT02356614?
This trial is sponsored by Apollo Endosurgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.